Adoptive Cell Therapy
Screening Platform
Screening Platform is flagged as a platform signal because it has an active early-phase oncology cell-therapy trial at GlaxoSmithKline, with a possible patent signal linked through modality_match. Manual review is still required.
Phase2 · Terminated
View asset